104 related articles for article (PubMed ID: 11810554)
1. Effects of fluconazole on viable cell count in experimental intraperitoneal Candida abscesses.
Mikamo H; Hua YX; Hayasaki Y; Sato Y; Tamaya T
J Infect Chemother; 2000 Sep; 6(3):144-7. PubMed ID: 11810554
[TBL] [Abstract][Full Text] [Related]
2. Effect of ravuconazole, a new triazole antifungal, in a rat intraabdominal abscess model.
Mikamo H; Yin XH; Hayasaki Y; Satoh M; Tamaya T
Chemotherapy; 2001; 47(5):377-80. PubMed ID: 11561141
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.
Krishnan-Natesan S; Manavathu EK; Cutright JL; Chandrasekar PH
Int J Antimicrob Agents; 2010 Jul; 36(1):33-6. PubMed ID: 20400270
[TBL] [Abstract][Full Text] [Related]
4. Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model.
Andes D; van Ogtrop M
Antimicrob Agents Chemother; 1999 Sep; 43(9):2116-20. PubMed ID: 10471550
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of fluconazole in murine Candida albicans and bacterial C. albicans peritonitis and abscess formation.
Sawyer RG; Adams RB; Rosenlof LK; May AK; Pruett TL
J Med Vet Mycol; 1995; 33(2):131-6. PubMed ID: 7658305
[TBL] [Abstract][Full Text] [Related]
6. Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.
Vonk AG; Netea MG; van Krieken JH; Verweij PE; van der Meer JW; Kullberg BJ
Antimicrob Agents Chemother; 2003 Dec; 47(12):3688-93. PubMed ID: 14638466
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
Ninomiya M; Mikamo H; Tanaka K; Watanabe K; Tamaya T
J Antimicrob Chemother; 2005 Apr; 55(4):587-90. PubMed ID: 15728144
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
Majithiya J; Sharp A; Parmar A; Denning DW; Warn PA
J Antimicrob Chemother; 2009 Jan; 63(1):161-6. PubMed ID: 19008255
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
Khan MA; Khan A; Owais M
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M
J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
Bannatyne RM; Cheng PC; Fong IW
Infection; 1992; 20(3):168-70. PubMed ID: 1644494
[TBL] [Abstract][Full Text] [Related]
12. A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.
Bassetti M; Marchetti M; Chakrabarti A; Colizza S; Garnacho-Montero J; Kett DH; Munoz P; Cristini F; Andoniadou A; Viale P; Rocca GD; Roilides E; Sganga G; Walsh TJ; Tascini C; Tumbarello M; Menichetti F; Righi E; Eckmann C; Viscoli C; Shorr AF; Leroy O; Petrikos G; De Rosa FG
Intensive Care Med; 2013 Dec; 39(12):2092-106. PubMed ID: 24105327
[TBL] [Abstract][Full Text] [Related]
13. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
Kamai Y; Kakuta M; Shibayama T; Fukuoka T; Kuwahara S
Antimicrob Agents Chemother; 2005 Jan; 49(1):52-6. PubMed ID: 15616275
[TBL] [Abstract][Full Text] [Related]
15. ZD0870 treatment of murine candidiasis caused by fluconazole resistant isolates of Candida albicans.
Najvar LK; Correa A; James P; Luther MF; Graybill JR
J Antimicrob Chemother; 1996 Oct; 38(4):671-7. PubMed ID: 8937961
[TBL] [Abstract][Full Text] [Related]
16. Tinospora cordifolia Aqueous Extract Alleviates Cyclophosphamide- Induced Immune Suppression, Toxicity and Systemic Candidiasis in Immunosuppressed Mice: In vivo Study in Comparison to Antifungal Drug Fluconazole.
Alrumaihi F; Allemailem KS; Almatroudi A; Alsahli MA; Khan A; Khan MA
Curr Pharm Biotechnol; 2019; 20(12):1055-1063. PubMed ID: 31333126
[TBL] [Abstract][Full Text] [Related]
17. Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis.
Wang Y; Jia XM; Jia JH; Li MB; Cao YY; Gao PH; Liao WQ; Cao YB; Jiang YY
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e40-6. PubMed ID: 19413603
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of prophylactic and early fluconazole treatment on systemic candidiasis in experimentally neutropenic rabbits.
Ozgüneş I; Usluer G; Güer F; Colak H
Chemotherapy; 1993; 39(3):189-96. PubMed ID: 8508689
[TBL] [Abstract][Full Text] [Related]
19. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study.
Zilberberg M; Yu HT; Chaudhari P; Emons MF; Khandelwal N; Shorr AF
Crit Care; 2014 Oct; 18(5):590. PubMed ID: 25358521
[TBL] [Abstract][Full Text] [Related]
20. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
Schreiber W; Olbrisch A; Vorwerk CK; König W; Behrens-Baumann W
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2634-43. PubMed ID: 12766067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
